GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Zymergen Inc (NAS:ZY) » Definitions » Days Sales Outstanding

Zymergen (Zymergen) Days Sales Outstanding : 31.07 (As of Jun. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Zymergen Days Sales Outstanding?

Zymergen's average Accounts Receivable for the three months ended in Jun. 2022 was $0.82 Mil. Zymergen's Revenue for the three months ended in Jun. 2022 was $2.42 Mil. Hence, Zymergen's Days Sales Outstanding for the three months ended in Jun. 2022 was 31.07.

The historical rank and industry rank for Zymergen's Days Sales Outstanding or its related term are showing as below:

ZY' s Days Sales Outstanding Range Over the Past 10 Years
Min: 33.09   Med: 57.55   Max: 67.96
Current: 47.7

During the past 3 years, Zymergen's highest Days Sales Outstanding was 67.96. The lowest was 33.09. And the median was 57.55.

ZY's Days Sales Outstanding is not ranked
in the Chemicals industry.
Industry Median: 64.05 vs ZY: 47.70

Zymergen's Days Sales Outstanding declined from Jun. 2021 (65.62) to Jun. 2022 (31.07).


Zymergen Days Sales Outstanding Historical Data

The historical data trend for Zymergen's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zymergen Days Sales Outstanding Chart

Zymergen Annual Data
Trend Dec19 Dec20 Dec21
Days Sales Outstanding
57.55 67.96 33.09

Zymergen Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 65.62 78.71 23.48 8.96 31.07

Competitive Comparison of Zymergen's Days Sales Outstanding

For the Specialty Chemicals subindustry, Zymergen's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zymergen's Days Sales Outstanding Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Zymergen's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Zymergen's Days Sales Outstanding falls into.



Zymergen Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Zymergen's Days Sales Outstanding for the fiscal year that ended in Dec. 2021 is calculated as

Days Sales Outstanding (A: Dec. 2021 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2020 ) + Accounts Receivable (A: Dec. 2021 )) / count ) / Revenue (A: Dec. 2021 )*Days in Period
=( (2.516 + 0.52) / 2 ) / 16.743*365
=1.518 / 16.743*365
=33.09

Zymergen's Days Sales Outstanding for the quarter that ended in Jun. 2022 is calculated as:

Days Sales Outstanding (Q: Jun. 2022 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2022 ) + Accounts Receivable (A: Jun. 2022 )) / count ) / Revenue (A: Jun. 2022 )*Days in Period
=( (0.374 + 1.272) / 2 ) / 2.417*365 / 4
=0.823 / 2.417*365 / 4
=31.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zymergen  (NAS:ZY) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Zymergen Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Zymergen's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Zymergen (Zymergen) Business Description

Traded in Other Exchanges
N/A
Address
5980 Horton Street, Suite 105, Emeryville, CA, USA, 94608
Zymergen Inc is a biofacturing company. Zymergen partners with nature to design, develop and manufacture bio-based breakthrough products that deliver value to customers in a broad range of industries. A unique combination of biology, chemistry, software and automation enables the company to design and create new materials.
Executives
Enakshi Singh officer: Chief Financial Officer 5980 HORTON ST., STE 105 EMERYVILLE CA 94608
Mina Kim officer: Chief Legal Officer C/O ACELYRIN, INC., 4149 LIBERTY CANYON RD., AGOURA HILLS CA 91301
Zachariah Serber director, officer: Chief Science Officer 5980 HORTON ST., STE 105 EMERYVILLE CA 94608
Aaron Kimball officer: Chief Technology Officer 5980 HORTON ST., STE 105 EMERYVILLE CA 94025
Jay T Flatley director 9885 TOWNE CENTRE DR, SAN DIEGO CA 92121
Svf Excaliber (cayman) Ltd 10 percent owner 27 HOSPITAL ROAD, WALKERS CORPORATE LTD., CAYMAN CORPORATE CENTRE, GEORGE TOWN, GRAND CAYMAN E9 KY-9008
Josh Hoffman director, officer: Chief Executive Officer 5980 HORTON ST., STE 105 EMERYVILLE CA 94608
Erik Jedidiah Dean officer: VP Operations and Engineering 5980 HORTON ST., STE 105 EMERYVILLE CA 94608
Rohit Sharma director 575 HIGH STREET PALO ALTO CA 94301
Travis Murdoch director 1 CIRCLE STAR WAY SAN CARLOS CA 94070
Matthew Ocko director 270 UNIVERSITY AVENUE, PALO ALTO CA 94301
Svf Endurance (cayman) Ltd 10 percent owner C/O WALKERS CORPORATE LIMITED, 27 HOSPITAL ROAD, GEORGE TOWN E9 KY1-9008
Softbank Vision Fund (aiv M1) L.p. 10 percent owner 251 LITTLE FALLS DRIVE, WILMINGTON DE 19808
Sb Investment Advisers (uk) Ltd 10 percent owner 69 GROSVENOR STREET, LONDON X0 W1K 3JP
Christine Marie Gorjanc director 4500 GREAT AMERICA PARKWAY, SANTA CLARA CA 95054